Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does CABOTEGRAVIR Cause Pathogen resistance? 270 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 270 reports of Pathogen resistance have been filed in association with CABOTEGRAVIR (Apretude). This represents 3.3% of all adverse event reports for CABOTEGRAVIR.

270
Reports of Pathogen resistance with CABOTEGRAVIR
3.3%
of all CABOTEGRAVIR reports
0
Deaths
12
Hospitalizations

How Dangerous Is Pathogen resistance From CABOTEGRAVIR?

Of the 270 reports, 12 (4.4%) required hospitalization, and 5 (1.9%) were considered life-threatening.

Is Pathogen resistance Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for CABOTEGRAVIR. However, 270 reports have been filed with the FAERS database.

What Other Side Effects Does CABOTEGRAVIR Cause?

Product dose omission issue (1,121) Off label use (1,049) Injection site pain (924) Viral load increased (452) Pain (399) Virologic failure (275) Pyrexia (255) Product use in unapproved therapeutic environment (234) Inappropriate schedule of product administration (228) Product complaint (213)

What Other Drugs Cause Pathogen resistance?

LAMIVUDINE (1,733) TENOFOVIR DISOPROXIL (811) DOLUTEGRAVIR (586) EFAVIRENZ (567) ZIDOVUDINE (552) RALTEGRAVIR (425) CLARITHROMYCIN (423) LEVOFLOXACIN (414) METRONIDAZOLE (404) CIPROFLOXACIN (377)

Which CABOTEGRAVIR Alternatives Have Lower Pathogen resistance Risk?

CABOTEGRAVIR vs CABOTEGRAVIR\RILPIVIRINE CABOTEGRAVIR vs CABOZANTINIB CABOTEGRAVIR vs CABOZANTINIB S-MALATE CABOTEGRAVIR vs CAFFEINE CABOTEGRAVIR vs CALASPARGASE PEGOL

Related Pages

CABOTEGRAVIR Full Profile All Pathogen resistance Reports All Drugs Causing Pathogen resistance CABOTEGRAVIR Demographics